Search results for "Anesthesia"

showing 10 items of 2277 documents

Adequate analgesia and sedation should be given to neonates during non‐emergency endotracheal intubation

2019

Nociceptionbusiness.industryPremedicationSedationInfant NewbornMEDLINEEndotracheal intubationGeneral MedicineAnesthesiaPediatrics Perinatology and Child HealthIntubation IntratrachealHumansMedicineNeonatologymedicine.symptombusinessActa Paediatrica
researchProduct

Neuropathic pain. Redefinition and a grading system for clinical and research purposes.

2008

Pain usually results from activation of nociceptive afferents by actually or potentially tissue-damaging stimuli. Pain may also arise by activity generated within the nervous system without adequate stimulation of its peripheral sensory endings. For this type of pain, the International Association for the Study of Pain introduced the term neuropathic pain, defined as "pain initiated or caused by a primary lesion or dysfunction in the nervous system." While this definition has been useful in distinguishing some characteristics of neuropathic and nociceptive types of pain, it lacks defined boundaries. Since the sensitivity of the nociceptive system is modulated by its adequate activation (e.g…

NosologyDiagnostic Imagingmedicine.medical_specialtySensory systemNeurological disorderDiseaseSomatosensory systemSeverity of Illness IndexPhysical medicine and rehabilitationTerminology as TopicmedicineHumansPain MeasurementNeurologic Examinationbusiness.industryNociceptorsPeripheral Nervous System Diseasesmedicine.diseaseNociceptionAnesthesiaNeuropathic painNeuralgiaNeuralgiaNeurology (clinical)businessAlgorithms
researchProduct

Incident cardiovascular events in severely obese patients treated with continous positive airway pressure (CPAP)/non invasive ventilation (NIV): A 5.…

2015

it is still debated whether CPAP or non-invasive ventilation (NIV) reduces cardiovascular (CV) risk in morbidly obese patients. Obese subjects affected by obstructive sleep apnea (OSA) or obesity hypoventilation syndrome (OHS) (n=210) were recruited between 2007-2010 in the Sleep Center, Univ. of Grenoble; 152 of them were treated with CPAP or NIV, and regularly followed by a home-care provider (Agir a dom). Patients underwent phone interviews to assess incident CV events during 5.6 years (range 4.0-6.5 yrs) of follow-up. One hundred seventeen patients (63 men) responded to questionnaire, 3 OSA patients died, and 32 declined/were lost to follow-up (response rate 77%). All patients at baseli…

Obesity hypoventilation syndromeResponse rate (survey)medicine.medical_specialtymedicine.diagnostic_testbusiness.industryPhysical examinationmedicine.diseasenervous system diseasesrespiratory tract diseasesSurgeryObstructive sleep apneasymbols.namesakeAnesthesiaPositive airway pressuremedicineBreathingsymbolsRespiratory functionPoisson regressionbusiness4.2 Sleep and Control of Breathing
researchProduct

Efficacy of obidoxime in human organophosphorus poisoning: determination by neuromuscular transmission studies.

1995

Six patients with organophosphorus compound intoxications developed an intermediate syndrome (weakness and fasciculations) and obidoxime was given on eight occasions. The efficacy of the acetylcholinesterase (AChE) reactivator was monitored electrophysiologically by neuromuscular transmission studies using single and repetitive nerve stimulation (20 and 50 Hz) and the activity of the serum (butyryl) cholinesterase (ChE). Dramatic electrophysiologic improvement was seen when obidoxime was given early within 12 h in 3 patients, although evidence of AChE inhibition did not subside completely. When administration of obidoxime was delayed 26 h or more after intoxication on five occasions, electr…

ObidoximeMaleObidoxime ChloridePhysiologyNeuromuscular transmissionNeuromuscular JunctionAction PotentialsSynaptic TransmissionNeuromuscular junctionFasciculationCellular and Molecular Neurosciencechemistry.chemical_compoundOrganophosphate PoisoningPhysiology (medical)medicineHumansRepetitive nerve stimulationCholinesteraseAgedbiologybusiness.industryMusclesMiddle AgedAcetylcholinesterasemedicine.anatomical_structureBiochemistrychemistryThumbAnesthesiabiology.proteinFemaleNeurology (clinical)medicine.symptombusinessAcetylcholinemedicine.drugMusclenerve
researchProduct

Heart rate variability during sleep in patients with schizophrenia treated with olanzapine.

2004

Cardiac adverse events in patients treated with atypical antipsychotics have gained increasing interest in recent years. In the present study, heart rate variability (HRV), which is a sensitive parameter reflecting central autonomic cardiac control, was investigated during treatment with olanzapine. Ten physically healthy male patients with schizophrenia, who displayed predominantly negative symptoms, were studied in the sleep laboratory under drug-free baseline conditions and after 4 weeks of olanzapine medication. HRV was assessed during different sleep stages both in the time and frequency domains. Only slight changes in HRV were shown during treatment, and appeared to be independent of …

OlanzapineAdultMalePsychosisAdolescentmedicine.drug_classAtypical antipsychoticBenzodiazepinesHeart RateHeart ratemedicineHeart rate variabilityHumansPharmacology (medical)Sleep StagesDose-Response Relationship DrugDopamine antagonistElectroencephalographymedicine.diseasePsychiatry and Mental healthSchizophreniaOlanzapineAnesthesiaSchizophreniaSleep StagesPsychologymedicine.drugAntipsychotic AgentsInternational clinical psychopharmacology
researchProduct

Reduction of olfactory sensitivity during normobaric hypoxia.

2018

Abstract Objective Acute mountain sickness (AMS) is caused by a low partial pressure of oxygen and may occur above 2500 m. The aim of this research was to evaluate olfactory and gustatory abilities of healthy subjects during baseline conditions and after seven hours of normobaric hypoxia. Methods Sixteen healthy subjects were assessed using the Sniffin’ Sticks, as well as intensity and pleasantness ratings. Gustatory function was evaluated utilizing the Taste Strips. Experiments were carried out under baseline conditions (518 m altitude) followed by a second testing session after seven hours of normobaric hypoxia exposure (comparable to 4000 m altitude). Results During normobaric hypoxia ol…

Olfactory systemMaleTasteAltitude Sickness03 medical and health sciencesYoung Adult0302 clinical medicineMedicineHumans030223 otorhinolaryngologyHypoxiaNormobaric hypoxiabusiness.industryAltitudeHealthy subjectsGeneral MedicineOlfactory PerceptionHealthy VolunteersSmellOtorhinolaryngologyAnesthesiaSensory ThresholdsTaste ThresholdSurgerybusiness030217 neurology & neurosurgeryAuris, nasus, larynx
researchProduct

Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial

2014

BACKGROUND: In patients with relapsing-remitting MS (RRMS) fingolimod prevents disease relapses and delays disability progression. First dose administration of fingolimod is associated with a transient, dose-dependent decrease in heart rate (HR) in the 6 hours after drug intake.The aim of the study is to to assess safety and tolerability of the first dose of fingolimod in a cohort of Italian patients with RRMS without alternative therapeutic options. METHODS: Open-label, single arm, multicentre study. After the first dose of fingolimod, patients were observed for 6 hours and had their vital signs monitored hourly. Extended on-site monitoring was provided when required. RESULTS: Of the 906 p…

OncologyMaleNeurologyfingolimod multiple sclerosis treatment first dose safetyadministration /&/ dosage/adverse effects/analogs /&/ derivatives/therapeutic useImmunosuppressive AgentSphingosineMultiple SclerosiAtrioventricular Blockadministration /&/ dosage/adverse effects/therapeutic useGeneral MedicineMiddle AgedTolerabilityPropylene GlycolFingolimoddrug therapyTolerabilityAnesthesiaCohortAdolescent Adult Atrioventricular Block; chemically induced/epidemiology Drug Therapy; Combination Female Humans Immunosuppressive Agents; administration /&/ dosage/adverse effects/therapeutic use Male Middle Aged Multiple Sclerosis; drug therapy Propylene Glycols; administration /&/ dosage/adverse effects/therapeutic use Sphingosine; administration /&/ dosage/adverse effects/analogs /&/ derivatives/therapeutic use Young AdultCombinationDrug Therapy CombinationSettore MED/26 - NeurologiaFemaleAtrioventricular block; Bradycardia; Fingolimod; Multiple sclerosis; Safety; Tolerability; Adolescent; Adult; Atrioventricular Block; Drug Therapy Combination; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis; Propylene Glycols; Sphingosine; Young Adult; Neurology (clinical)SafetyAtrioventricular block Bradicardia Multiple sclerosis Fingolimod Safety TolerabilityImmunosuppressive AgentsResearch ArticleHumanmedicine.drugAdultmedicine.medical_specialtyMultiple SclerosisAdolescentClinical NeurologyYoung AdultFingolimod HydrochlorideInternal medicineBradycardiamedicineHumansNeurochemistryFingolimod Hydrochloridebusiness.industryMultiple sclerosisFingolimodmedicine.diseaseClinical trialPropylene GlycolsAtrioventricular block Bradycardia Multiple sclerosis Fingolimod Safety Tolerabilitychemically induced/epidemiologyNeurology (clinical)business
researchProduct

Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting

1995

OndansetronCancer ResearchOncologybusiness.industryAnesthesiamedicineGranisetronbusinessmedicine.drugChemotherapy-induced nausea and vomitingCancer
researchProduct

High flow nasal therapy in perioperative medicine: from operating room to general ward

2018

Abstract Background High flow nasal therapy (HFNT) is a technique in which humidified and heated gas is delivered to the airways through the nose via small nasal prongs at flows that are higher than the rates generally applied during conventional oxygen therapy. The delivered high flow rates combine mixtures of air and oxygen and enable different inspired oxygen fractions ranging from 0.21 to 1. HFNT is increasingly used in critically ill adult patients, especially hypoxemic patients in different clinical settings. Main body Noninvasive ventilation delivers positive pressure (end-expiratory and inspiratory pressures or continuous positive airway pressure) via different external interfaces. …

Operating Roomsmedicine.medical_specialtymedicine.medical_treatmentPositive pressureReviewAcute respiratory failurePerioperative CarePerioperative medicinelcsh:RD78.3-87.303 medical and health sciences0302 clinical medicineOxygen therapyAnesthesiologyPatients' RoomsIntubation IntratrachealmedicineHumansIntubationContinuous positive airway pressureAdministration IntranasalHigh flow nasal therapyNosePerioperative medicinebusiness.industryOxygen Inhalation TherapyHumidity030208 emergency & critical care medicineOxygenationAnesthesiology and Pain Medicinemedicine.anatomical_structure030228 respiratory systemlcsh:AnesthesiologyAnesthesiaNasal CavitybusinessNoninvasive ventilationBMC Anesthesiology
researchProduct

Hyperventilation in Severe Traumatic Brain Injury Has Something Changed in the Last Decade or Uncertainty Continues? A Brief Review

2021

Opinionbusiness.industryTraumatic brain injuryhyperventilationintracranial pressureCerebral hypoxiamedicine.diseaselcsh:RC346-429cerebral ischemiacerebral hypoxiahypocapniaHypocapniaNeurologyAnesthesiaintracranial hypertensionHyperventilationMedicineNeurology (clinical)medicine.symptombusinesssevere traumatic brain injurylcsh:Neurology. Diseases of the nervous systemIntracranial pressureFrontiers in Neurology
researchProduct